Endoplasmic reticulum stress as a novel mechanism in amiodaroneinduced destructive thyroiditis

Angela Lombardi, William Barlow Inabnet, Randall Owen, Kaitlyn Ellen Farenholtz, Yaron Tomer

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Context: Amiodarone (AMIO) is one of the most effective antiarrhythmic drugs available; however, its use is limited by a serious side effect profile, including thyroiditis. The mechanisms underlying AMIO thyroid toxicity have been elusive; thus, identification of novel approaches in order to prevent thyroiditis is essential in patients treated with AMIO. Objective: Our aim was to evaluate whether AMIO treatment could induce endoplasmic reticulum (ER) stress in human thyroid cells and the possible implications of this effect in AMIO-induced destructive thyroiditis. Results: Here we report that AMIO, but not iodine, significantly induced the expression of ER stress markersincluding Igheavychain-binding protein (BiP), phosphoeukaryotic translation initiation factor 2α(eIF2α), CCAAT/enhancer-binding protein homologous protein (CHOP) and spliced X-box binding protein-1 (XBP-1) in human thyroid ML-1 cells and human primary thyrocytes. In both experimental systems AMIO down-regulated thyroglobulin (Tg) protein but had little effect on Tg mRNA levels, suggesting a mechanism involving Tg protein degradation. Indeed, pretreatment with the specific proteasome inhibitor MG132 reversed AMIO-induced down-regulation of Tg protein levels, confirming a proteasome-dependent degradation of Tg protein. Corroborating our findings, pretreatment of ML-1cellsandhumanprimarythyrocyteswiththechemicalchaperone4-phenylbutyric acidcompletely prevented the effect of AMIO on both ER stress induction and Tg down-regulation. Conclusions: We identified ER stress as a novel mechanism contributing to AMIO-induced destructive thyroiditis. Our data establish that AMIO-induced ER stress impairs Tg expression via proteasome activation, providing a valuable therapeutic avenue for the treatment of AMIO-induced destructive thyroiditis.

Original languageEnglish (US)
Pages (from-to)E1-E10
JournalJournal of Clinical Endocrinology and Metabolism
Volume100
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Thyroiditis
Endoplasmic Reticulum Stress
Amiodarone
Thyroglobulin
Thyroid Gland
Proteasome Endopeptidase Complex
Proteins
Proteolysis
Carrier Proteins
Translational Peptide Chain Initiation
Down-Regulation
Prokaryotic Initiation Factor-2
CCAAT-Enhancer-Binding Proteins
Degradation
Proteasome Inhibitors
Anti-Arrhythmia Agents
Iodine
Toxicity
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Endoplasmic reticulum stress as a novel mechanism in amiodaroneinduced destructive thyroiditis. / Lombardi, Angela; Inabnet, William Barlow; Owen, Randall; Farenholtz, Kaitlyn Ellen; Tomer, Yaron.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 100, No. 1, 01.01.2015, p. E1-E10.

Research output: Contribution to journalArticle

Lombardi, Angela ; Inabnet, William Barlow ; Owen, Randall ; Farenholtz, Kaitlyn Ellen ; Tomer, Yaron. / Endoplasmic reticulum stress as a novel mechanism in amiodaroneinduced destructive thyroiditis. In: Journal of Clinical Endocrinology and Metabolism. 2015 ; Vol. 100, No. 1. pp. E1-E10.
@article{43db83d680b9429dabc11f74abe2e486,
title = "Endoplasmic reticulum stress as a novel mechanism in amiodaroneinduced destructive thyroiditis",
abstract = "Context: Amiodarone (AMIO) is one of the most effective antiarrhythmic drugs available; however, its use is limited by a serious side effect profile, including thyroiditis. The mechanisms underlying AMIO thyroid toxicity have been elusive; thus, identification of novel approaches in order to prevent thyroiditis is essential in patients treated with AMIO. Objective: Our aim was to evaluate whether AMIO treatment could induce endoplasmic reticulum (ER) stress in human thyroid cells and the possible implications of this effect in AMIO-induced destructive thyroiditis. Results: Here we report that AMIO, but not iodine, significantly induced the expression of ER stress markersincluding Igheavychain-binding protein (BiP), phosphoeukaryotic translation initiation factor 2α(eIF2α), CCAAT/enhancer-binding protein homologous protein (CHOP) and spliced X-box binding protein-1 (XBP-1) in human thyroid ML-1 cells and human primary thyrocytes. In both experimental systems AMIO down-regulated thyroglobulin (Tg) protein but had little effect on Tg mRNA levels, suggesting a mechanism involving Tg protein degradation. Indeed, pretreatment with the specific proteasome inhibitor MG132 reversed AMIO-induced down-regulation of Tg protein levels, confirming a proteasome-dependent degradation of Tg protein. Corroborating our findings, pretreatment of ML-1cellsandhumanprimarythyrocyteswiththechemicalchaperone4-phenylbutyric acidcompletely prevented the effect of AMIO on both ER stress induction and Tg down-regulation. Conclusions: We identified ER stress as a novel mechanism contributing to AMIO-induced destructive thyroiditis. Our data establish that AMIO-induced ER stress impairs Tg expression via proteasome activation, providing a valuable therapeutic avenue for the treatment of AMIO-induced destructive thyroiditis.",
author = "Angela Lombardi and Inabnet, {William Barlow} and Randall Owen and Farenholtz, {Kaitlyn Ellen} and Yaron Tomer",
year = "2015",
month = "1",
day = "1",
doi = "10.1210/jc.20142745",
language = "English (US)",
volume = "100",
pages = "E1--E10",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Endoplasmic reticulum stress as a novel mechanism in amiodaroneinduced destructive thyroiditis

AU - Lombardi, Angela

AU - Inabnet, William Barlow

AU - Owen, Randall

AU - Farenholtz, Kaitlyn Ellen

AU - Tomer, Yaron

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Context: Amiodarone (AMIO) is one of the most effective antiarrhythmic drugs available; however, its use is limited by a serious side effect profile, including thyroiditis. The mechanisms underlying AMIO thyroid toxicity have been elusive; thus, identification of novel approaches in order to prevent thyroiditis is essential in patients treated with AMIO. Objective: Our aim was to evaluate whether AMIO treatment could induce endoplasmic reticulum (ER) stress in human thyroid cells and the possible implications of this effect in AMIO-induced destructive thyroiditis. Results: Here we report that AMIO, but not iodine, significantly induced the expression of ER stress markersincluding Igheavychain-binding protein (BiP), phosphoeukaryotic translation initiation factor 2α(eIF2α), CCAAT/enhancer-binding protein homologous protein (CHOP) and spliced X-box binding protein-1 (XBP-1) in human thyroid ML-1 cells and human primary thyrocytes. In both experimental systems AMIO down-regulated thyroglobulin (Tg) protein but had little effect on Tg mRNA levels, suggesting a mechanism involving Tg protein degradation. Indeed, pretreatment with the specific proteasome inhibitor MG132 reversed AMIO-induced down-regulation of Tg protein levels, confirming a proteasome-dependent degradation of Tg protein. Corroborating our findings, pretreatment of ML-1cellsandhumanprimarythyrocyteswiththechemicalchaperone4-phenylbutyric acidcompletely prevented the effect of AMIO on both ER stress induction and Tg down-regulation. Conclusions: We identified ER stress as a novel mechanism contributing to AMIO-induced destructive thyroiditis. Our data establish that AMIO-induced ER stress impairs Tg expression via proteasome activation, providing a valuable therapeutic avenue for the treatment of AMIO-induced destructive thyroiditis.

AB - Context: Amiodarone (AMIO) is one of the most effective antiarrhythmic drugs available; however, its use is limited by a serious side effect profile, including thyroiditis. The mechanisms underlying AMIO thyroid toxicity have been elusive; thus, identification of novel approaches in order to prevent thyroiditis is essential in patients treated with AMIO. Objective: Our aim was to evaluate whether AMIO treatment could induce endoplasmic reticulum (ER) stress in human thyroid cells and the possible implications of this effect in AMIO-induced destructive thyroiditis. Results: Here we report that AMIO, but not iodine, significantly induced the expression of ER stress markersincluding Igheavychain-binding protein (BiP), phosphoeukaryotic translation initiation factor 2α(eIF2α), CCAAT/enhancer-binding protein homologous protein (CHOP) and spliced X-box binding protein-1 (XBP-1) in human thyroid ML-1 cells and human primary thyrocytes. In both experimental systems AMIO down-regulated thyroglobulin (Tg) protein but had little effect on Tg mRNA levels, suggesting a mechanism involving Tg protein degradation. Indeed, pretreatment with the specific proteasome inhibitor MG132 reversed AMIO-induced down-regulation of Tg protein levels, confirming a proteasome-dependent degradation of Tg protein. Corroborating our findings, pretreatment of ML-1cellsandhumanprimarythyrocyteswiththechemicalchaperone4-phenylbutyric acidcompletely prevented the effect of AMIO on both ER stress induction and Tg down-regulation. Conclusions: We identified ER stress as a novel mechanism contributing to AMIO-induced destructive thyroiditis. Our data establish that AMIO-induced ER stress impairs Tg expression via proteasome activation, providing a valuable therapeutic avenue for the treatment of AMIO-induced destructive thyroiditis.

UR - http://www.scopus.com/inward/record.url?scp=84920570441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920570441&partnerID=8YFLogxK

U2 - 10.1210/jc.20142745

DO - 10.1210/jc.20142745

M3 - Article

C2 - 25295624

AN - SCOPUS:84920570441

VL - 100

SP - E1-E10

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -